Point72 Asset Management
MLTX icon

Point72 Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Point72 Asset Management’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$8.81M Buy
2025
Q1 		– Sell
2024
Q4 		$5.35M Buy
2024
Q1 		– Hold
2023
Q4 		– Hold
2023
Q2 		– Sell
2023
Q1 		$636K Buy
2022
Q4 		– Sell
2022
Q3 		$2.6M Buy
2021
Q1 		– Sell
2020
Q4 		$796K Buy